Looking back, O’Toole believes strongly that the key to designing a full and successful post-corporate portfolio life is ...

The proof of concept revealed AI-based attacks unfold too fast for human defenders to respond, and that AI evinced more ...

A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

The cost of training today’s large-scale foundation models is often reduced to a single number: the price of a GPU hour. It's ...